tradingkey.logo

Utah Medical Products Inc

UTMD

56.480USD

+1.530+2.78%
交易中 美东报价延迟15分钟
185.31M总市值
14.30市盈率 TTM

Utah Medical Products Inc

56.480

+1.530+2.78%
关于 Utah Medical Products Inc 公司
Utah Medical Products, Inc. 从事医疗服务生产业务。该公司销售一系列用于重症监护领域的医疗设备,尤其是医院的新生儿重症监护室 (NICU)、分娩 (L&D) 部门和妇女健康中心,以及销售给门诊诊所和医生办公室的医疗设备。其产品包括 BT-CATH、CVX-RIPE、AROM-COT、MUC-X、CORDGUARD、DISPOSA-HOOD、DELTRAN PLUS、GESCO、PICC-NATE、LETZ System、Filshie Clip System、PATHFINDER PLUS、SUPRAPUBIC CATHETERIZATION、LIBERTY System、ENDOCURETTE、LUMIN 和 BioPharm HP-PRT 等。BT-CATH 是一种用于控制严重产后出血的子宫球囊填塞导管。 MUC-X 是一种在新生儿出生后立即使用的抽吸装置,用于清理新生儿呼吸道并减少潜在感染风险。AROM-CO 是一种带叉的指套,用于破膜,减轻患者的疼痛和焦虑。
公司简介
公司代码UTMD
公司名称Utah Medical Products Inc
上市日期Dec 01, 1982
CEOMr. Kevin L. Cornwell
员工数量155
证券类型Ordinary Share
年结日Dec 01
公司地址7043 S 300 West
城市MIDVALE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编84070
电话18015215301
网址http://www.utahmed.com
公司代码UTMD
上市日期Dec 01, 1982
CEOMr. Kevin L. Cornwell
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Gynecology/Electrosurgery/Urology
4.90M
50.42%
Neonatal
1.98M
20.41%
Blood Pressure Monitoring and Accessories
1.81M
18.61%
Obstetrics
1.02M
10.56%
暂无数据
业务
地区
业务USD
名称
营收
占比
Gynecology/Electrosurgery/Urology
4.90M
50.42%
Neonatal
1.98M
20.41%
Blood Pressure Monitoring and Accessories
1.81M
18.61%
Obstetrics
1.02M
10.56%
股东统计
更新时间: 5月27日 周二
更新时间: 5月27日 周二
持股股东
股东类型
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
7.46%
Renaissance Technologies LLC
6.70%
Dimensional Fund Advisors, L.P.
6.08%
Cornwell (Kevin L)
5.80%
The Vanguard Group, Inc.
5.43%
Other
68.53%
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
7.46%
Renaissance Technologies LLC
6.70%
Dimensional Fund Advisors, L.P.
6.08%
Cornwell (Kevin L)
5.80%
The Vanguard Group, Inc.
5.43%
Other
68.53%
股东类型
持股股东
占比
Investment Advisor
36.14%
Investment Advisor/Hedge Fund
22.29%
Hedge Fund
10.91%
Individual Investor
7.04%
Research Firm
1.29%
Bank and Trust
0.17%
Pension Fund
0.07%
Insurance Company
0.04%
Other
22.04%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
249
2.54M
78.08%
-661.03K
2025Q1
251
2.54M
78.08%
-658.65K
2024Q4
245
2.63M
77.47%
-634.89K
2024Q3
233
2.73M
78.80%
-558.16K
2024Q2
224
2.74M
78.05%
-528.35K
2024Q1
214
2.81M
78.59%
-191.73K
2023Q4
203
2.83M
78.07%
-204.85K
2023Q3
194
2.97M
81.82%
-7.55K
2023Q2
183
2.95M
81.20%
-24.79K
2023Q1
188
2.95M
81.27%
+25.77K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Brandes Investment Partners, L.P.
242.25K
7.46%
+79.28K
+48.65%
Mar 31, 2025
Renaissance Technologies LLC
217.71K
6.7%
-3.80K
-1.71%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
192.96K
5.94%
+6.26K
+3.35%
Mar 31, 2025
Cornwell (Kevin L)
188.47K
5.8%
--
--
Mar 03, 2025
The Vanguard Group, Inc.
176.37K
5.43%
-801.00
-0.45%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
145.40K
4.48%
-1.57K
-1.07%
Mar 31, 2025
Geode Capital Management, L.L.C.
107.78K
3.32%
+9.84K
+10.05%
Mar 31, 2025
Hotchkis and Wiley Capital Management, LLC
101.64K
3.13%
+26.46K
+35.20%
Mar 31, 2025
Minerva Advisors LLC
86.90K
2.68%
+8.51K
+10.86%
Mar 31, 2025
State Street Global Advisors (US)
80.15K
2.47%
-2.55K
-3.08%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Acquirers Small and Micro Deep Value ETF
1.05%
JPMorgan Active Small Cap Value ETF
0.44%
Lattice Hartford Multifactor Small Cap ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.23%
Royce Quant Small-Cap Quality Value ETF
0.22%
Fidelity Small-Mid Multifactor ETF
0.09%
WisdomTree U.S. SmallCap Dividend Fund
0.07%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.01%
查看更多
Acquirers Small and Micro Deep Value ETF
占比1.05%
JPMorgan Active Small Cap Value ETF
占比0.44%
Lattice Hartford Multifactor Small Cap ETF
占比0.25%
JPMorgan Fundamental Data Science Small Core ETF
占比0.23%
Royce Quant Small-Cap Quality Value ETF
占比0.22%
Fidelity Small-Mid Multifactor ETF
占比0.09%
WisdomTree U.S. SmallCap Dividend Fund
占比0.07%
iShares Micro-Cap ETF
占比0.04%
Avantis US Small Cap Equity ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.01%
分红派息
近5年累计派现 27.29M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 04, 2025
UTMD.NB Final Cash Dividend of gross USD 0.305 paid on Apr 03, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 03, 2025
Mar 14, 2025
Dec 11, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jan 03, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 03, 2025
Dec 16, 2024
Aug 02, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Oct 04, 2024 going ex on Sep 20, 2024
Sep 20, 2024
Oct 04, 2024
Sep 20, 2024
May 07, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 06, 2024
UTMD.NB Final Cash Dividend of gross USD 0.3 paid on Apr 03, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 03, 2024
Mar 14, 2024
Oct 31, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 03, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 03, 2024
Dec 14, 2023
Aug 02, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Oct 03, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 03, 2023
Sep 14, 2023
May 10, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jul 06, 2023 going ex on Jun 15, 2023
Jun 16, 2023
Jul 06, 2023
Jun 15, 2023
Feb 07, 2023
UTMD.NB Final Cash Dividend of gross USD 0.295 paid on Apr 04, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 04, 2023
Mar 16, 2023
Nov 02, 2022
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jan 04, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 04, 2023
Dec 15, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI